Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.tgtherapeutics.com
TG Therapeutics, Inc. News Releases
Get the latest updates from TG Therapeutics, Inc. News Releases directly as they happen.
Follow now 36 followers
Latest posts
Last updated 9 days ago
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
9 days ago
First quarter 2025 BRIUMVI U.S. net revenue of $119.7 million Raises full...
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
14 days ago
Conference call to be held Monday, May 5, 2025, at 8:30 AM...
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
about 1 month ago
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ...
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
about 1 month ago
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ...
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
about 1 month ago
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ...
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
2 months ago
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ...
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
2 months ago
Fourth quarter and full year 2024 BRIUMVI U.S. net revenue of $103.6...
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
3 months ago
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ...
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
3 months ago
Conference call to be held Monday, March 3, 2025, at 8:30 AM...
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
3 months ago
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ...
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
4 months ago
Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue...
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
4 months ago
Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT NEW...